Three Connecticut research institutions are partnering with a prestigious counterpart in Israel to fill a research void in metabolic diseases, such as obesity and diabetes, which affect billions of people worldwide.

The goal of the Metabolic Research Alliance is to unite the expertise at University of Connecticut, Yale University, The Jackson Laboratory (JAX), and the Weizmann Institute of Science on research projects that swiftly move investigations into clinical application and commercialization.

“These two diseases are growing exponentially, and with catastrophic individual and societal effects and costs,” said Dr. Milton Wallack, founder of the Connecticut Stem Cell Coalition and organizer of the alliance. “Unfortunately, relatively few new therapeutic options are being developed, despite the crisis.”